Grants and Contributions
About this information
In June 2016, as part of the Open Government Action Plan, the Treasury Board of Canada Secretariat (TBS) committed to increasing the transparency and usefulness of grants and contribution data and subsequently launched the Guidelines on the Reporting of Grants and Contributions Awards, effective April 1, 2018.
The rules and principles governing government grants and contributions are outlined in the Treasury Board Policy on Transfer Payments. Transfer payments are transfers of money, goods, services or assets made from an appropriation to individuals, organizations or other levels of government, without the federal government directly receiving goods or services in return, but which may require the recipient to provide a report or other information subsequent to receiving payment. These expenditures are reported in the Public Accounts of Canada. The major types of transfer payments are grants, contributions and \'other transfer payments\'.
Included in this category, but not to be reported under proactive disclosure of awards, are (1) transfers to other levels of government such as Equalization payments as well as Canada Health and Social Transfer payments. (2) Grants and contributions reallocated or otherwise redistributed by the recipient to third parties; and (3) information that would normally be withheld under the Access to Information Act and the Privacy Act.
$703,146.00
Sep 1, 2022
For-profit organization
Accelerating the Future of Next-Generation Autonomous Vehicle Designs by Advancing Wireless Power Transfer System Capabilities in Automobiles
998563
Some of the largest automotive players in the world see the future of the design of electronics in the next generation of automobiles will be increasingly wireless.
This project will see Solace Power collaborate with Tier 1 automotive suppliers to solve technical design challenges for EV and autonomous vehicle wireless power applications, as well as to simplify manufacturing of autonomous vehicles, and to improve reliability of interior and exterior vehicle features.
$102,000.00
Sep 1, 2022
For-profit organization
Elarex Viral Vectored Exosomal Vaccine Development and Stabilization
998641
Optimization of ultra-stable formulation for viral vectored vaccine, compatible with oral dosing
$500,000.00
Sep 1, 2022
For-profit organization
Vertical expansion and sustainability
999391
Automator Group Inc. is preparing to expand into new adjacent verticals. There are several fundamental systems that need to be built in order to accomodate the expansion and reduce the redundant development overhead (building the same features in multiple systems).
These systems include:
1. Global fields & fees management
2. Compliance PDF Filler
3. Enhanced File Storage
Once completed, additional teams will be hired to grow new business verticals, including: sales, onboarding, support, marketing and development.
$135,000.00
Sep 1, 2022
For-profit organization
Improving Protein Content in Pulse and Oilseed Crops
999784
AgGene is targeting the improvement of protein content in economically important pulse and oilseed crops through the use of advanced plant breeding technology. AgGene has characterized a portfolio of genetic targets that can be manipulated through the use of genome editing to drive high protein content in seed tissues. High protein seed commodities can be leveraged for the expanding plant protein sector to help position Canada as a global leader in plant-based protein production.
$10,192.50
Sep 1, 2022
For-profit organization
HTUO Biosciences Inc.-2022-2023-1000353
1000353
The purpose of this CanExport Innovation agreement is to support Canadian organizations to carry out activities related to pursuing opportunities that would lead to establishing new collaborative Research and Development (R&D) partnerships between the Recipient and foreign organizations in order to support R&D on the Recipient’s technology and advance its commercialization.
$10,000,000.00
Sep 1, 2022
For-profit organization
COVID-19 Vaccine: Phase 3 Clinical Trial of DNA-Based Vaccine Booster Covigenix VAX-001-1c
1000363
Entos has developed Covigenix VAX-001, a DNA Proteo-Lipid Vehicle (PLV) vaccine intended for the prevention of COVID-19 infection by SARS-CoV-2. In this project, Entos will advance the VAX-001-1c bivalent vaccine candidate through Phase 3 clinical trials to establish its safety and immunogenicity in healthy adults as a booster to approved vaccines.
$6,180.20
Sep 1, 2022
For-profit organization
Pentavere Research Group Inc.-2022-2023-1000726
1000726
The purpose of this CanExport Innovation agreement is to support Canadian organizations to carry out activities related to pursuing opportunities that would lead to establishing new collaborative Research and Development (R&D) partnerships between the Recipient and foreign organizations in order to support R&D on the Recipient’s technology and advance its commercialization.
$350,000.00
Sep 1, 2022
For-profit organization
Emergency landing module on an autonomous aircraft
1000761
Ribbit is retrofitting general aviation aircraft with software and hardware that enable fully autonomous flight. This technology will eventually be deployed to serve e-commerce wholesalers who have already signed up for Ribbit’s future autonomous cargo airline service.
$7,275.00
Sep 1, 2022
For-profit organization
IP Assist: Intellectual Property Strategy Engagement
1001925
The Project will support development of intellectual property capacity within the Firm.
$750,000.00
Sep 1, 2022
For-profit organization
KNXT EV Personnel Carrier
1002142
Demand for connected EV's among our customers, and in the mining utility vehicle market, is growing at a fast pace. The KNXT project represents Kovatera’s battery electric vehicle technology development.